期刊文献+

NKG2D-sMICA在原发性肝细胞癌中的表达及意义 被引量:2

The clinical significance of natural killer cell stimulatory receptor NKG2D and its soluble ligand MICA expession in hepatocellular carcinoma
原文传递
导出
摘要 目的探讨外周血中NK细胞活化性受体NKG2D及其可溶性配体MHC-I链相关蛋白A(sMICA)与原发性肝细胞癌(HCC)发生发展的关系,为HCC免疫治疗提供理论依据。方法随机选取HCC患者40例,术前收集其外周血,流式细胞术检测NKG2D的表达,ELISA检测血清中sMICA的水平,并与20例健康对照组比较,分析sMICA与HCC临床病理因素的关系。结果HCC组NKG2D的表达为(71.97±4.96)%,明显低于对照组的(91.45±3.16)%,两组之间差异有统计学意义(P<0.05)。肝癌sMICA水平较对照组显著升高(中位值191.3 pg/mL vs.74.9 pg/mL,P<0.05)。血清中sMICA水平高低与肝癌TNM分期和是否合并门静脉癌栓有关(P<0.05)。Spearman等级相关分析显示,sMICA水平与NKG2D的表达率呈显著负相关(r=-0.591,P<0.05)。结论HCC组NKG2D表达下降;其血清中sMICA水平与HCC的发生发展有密切关系,可能与NKG2D-sMICA参与了HCC免疫逃逸机制有关。 Objective To investigate the natural killer cell stimulatory receptor NKG2D and its soluble ligand MICA(sMICA) expression in peripheral blood in hepatocellular carcinoma(HCC).Methods Blood samples of 40 patients and 20 healthy persons were collected to detect NKG2D by flow cytometry analysis.Serum levels of sMICA were determined by ELISA.The association of sMICA levels wth clinical features were analyzed.Results The expression of NKG2D in HCC(71.97±4.96)% was significantly lower than that in healthy group(91.45±3.16)%.The serum levels of sMICA was found to be significantly elevated in HCC compared with heathy subjects(median,191.3pg/mL vs.74.9pg/mL,P0.05).The levels of sMICA correlated significantly with presence of tumor thrombi in portal vein and advanced clinical tumor-node-metastasis(P0.05).Spearman rank correlation displayed that the expression of NKG2D was negatively correlated with the levels of sMICA(r=-0.591,P0.05).Conclusions The expression of NKG2D in HCC is significantly decreased.The levels of sMICA correlates significantly with progression of HCC.NKG2D-sMICA may play a critical role in tumor immunological escape in HCC,and may contribute to HCC progression.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2010年第1期57-60,共4页 China Journal of General Surgery
关键词 肝肿瘤 NKG2D MHC-I链相关蛋白A 肿瘤免疫逃逸 Liver Neoplasms NKG2D MHC Class I-Related Chain A Tumor immunological Escape
  • 相关文献

参考文献11

  • 1王成龙,谭家麟.直肠癌病人外周血NK细胞和T淋巴细胞亚群数目的变化及其临床意义[J].中国普通外科杂志,2001,10(3):228-230. 被引量:15
  • 2Raulet DH. Roles of the NKG2 D immunoreceptor and its ligands[J]. Nat Rev Immunol,2003,3(10) :781 -790.
  • 3Siemens DR, Hu N, Sheikhi AK, et al. Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide [ J]. Cancer Res, 2008, 68 (12) :4746 -4753.
  • 4Gonzolez S, Groh V, Spies T. Immunobiology of human NKG2 D and its ligands [ J ]. Curr Top Microbiol Immunol, 2006,298(33) :121 -138.
  • 5Jinushi M, Takehara T, Tatsumi T, et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid [ J ]. Int J Cancer, 2003,104(3) :354 -361.
  • 6Angela Marten, Marie von Lilienfeld-Toal, Markus W, et al. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity [ J ]. lnt J Cancer, 2006,119 (10) :2359 -2365.
  • 7Wu JD, Higgins LM, Steinle A, et al. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer [ J ]. J Clin Invest,2004,114 (4) :560 - 568.
  • 8Groh V, Wu J, Yee C, et al. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation [J]. Nature,2002,419(9) :734 -738.
  • 9Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA in malignant diseases[J]. Int J Cancer, 2006,118(3) : 684 - 687.
  • 10Salih HR, Antropius H, Gieseke F. FunctionsI expression and release of ligands for the activating immunoreceptor NKG2 D in leukemia [J].Blood,2003,102(4) :1389 -1396.

二级参考文献4

共引文献14

同被引文献27

  • 1Yan Wang,Zhou Ye,Xue-Qin Meng and Shu-Sen ZhengDivision of Hepatobiliary and Pancreatic Surgery,Key Laboratory of Combined Multi-organ Transplantation,Ministry of Public Health,and Key Laboratory of Organ Transplantation Zhejiang Province, First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China.Expression of HLA-G in patients with hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(2):158-163. 被引量:17
  • 2张彩,许晓群,张建华,王郡甫,冯进波,张建,田志刚.MHCI类样分子(MICA)在部分肿瘤组织和肿瘤细胞系中的表达及临床意义[J].中国肿瘤临床,2005,32(21):1208-1211. 被引量:13
  • 3Bahram S.MIC genes:from genetics to biology[J].Adv Immunol,2000.76(1):1-60.
  • 4Bahram S,Bresnahan M,Geraghty DE,et al.A second lineage of mammalian major histocompatibility complex class I genes[J].Proc Natl Acad Sci USA,1994,91(14):6259-6263.
  • 5Bahram S,Mizuki N,Inoko H,et al.Nucleotide sequence of the hu-man MHC class I MICA gene[J].Immunogenetics,1996,44:80-81.
  • 6Fodil N,Pellet P,Laloux L,et al.MICA haplotypicdiversity[J].Im-munogenetics,1999,49:557-560.
  • 7Siemens DR,Hu N,Sheikhi AK,et al.Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain Related Molecule:Role of Nitric Oxide[J].Cancer Res,2008,68(12):4746-4753.
  • 8Pende D,Rivera P,Marcenaro S,et al.Major histocompatibility com-plex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes:analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity[J].Cancer Res,2002,62(21):6178-6186.
  • 9Groh V,Rhinehart R,Secrist H,et al.Broad tumor-associated expres-sion and recognition by tumor-derived gamma delta T cells of MICA and MICB[J].Proc Natl Acad Sci U S A.1999,96(12):6879-6884.
  • 10Raulet DH.Roles of t he N KG2D immunoreceptor and it s ligands[J].Nat Rev Immunol,2003,3(10):781-790.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部